Back to dashboard
CommercialCoverageMedium impact

11.17.06w, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)

Independence Blue Cross·Urology·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Days to comply

Summary

IBX updated their medical policy for surgical and minimally invasive treatments for urinary outlet obstruction due to benign prostatic hyperplasia (BPH). This policy change affects coverage criteria and billing guidelines for BPH procedures, effective January 1, 2026.

Action Required

Action needed
Before January 1, 2026: Billing team must review the full IBX policy 11.17.06w at the provided URL to identify specific coverage criteria changes for BPH procedures. Update prior authorization requirements and documentation standards in billing system as specified in the complete policy. Notify urology providers of any new coverage restrictions or requirements.